A Study to Evaluate the Safety and Immunogenicity of a Single Dose of H1ssF-3928 mRNA-LNP in Healthy Adults | MicrobiomeTrials← Back to trialsNCT05755620
A Study to Evaluate the Safety and Immunogenicity of a Single Dose of H1ssF-3928 mRNA-LNP in Healthy Adults
CompletedPHASE1INTERVENTIONAL
Trial Details
Start: 2023-04-05Est. Completion: 2025-10-03
Enrollment target: 50 participants Locations- Duke Vaccine and Trials Unit, Durham, North Carolina, United States
Other microbiome trials you might be interested in
EBVHSVVZVHPVCMV
Background:
* Infections caused by viruses are common causes of illnesses: the common cold, many ear infections, sore t…
Bethesda, United States
Influenza
The purpose of this study is to evaluate the effectiveness of CD388 in preventing symptomatic laboratory-confirmed influ…
Anniston, United StatesCompleted Oct 9, 2025
Completed
Influenza With PneumoniaPulmonary Aspergillosis
A prospective multi-center observational study to assess the incidence of influenza-associated pulmonary aspergillosis (…
Bruges, BelgiumCompleted May 18, 2026